Search Result "refractory/relapse"
CAR-T Therapy in Relapsed Refractory Multiple Myeloma
Journal: Current Medicinal Chemistry
Volume: 31 Issue: 27 Year: 2024 Page: 4362-4382
Author(s):
mTOR as a Target of Everolimus in Refractory/Relapsed Hodgkin Lymphoma
Journal: Current Medicinal Chemistry
Volume: 19 Issue: 7 Year: 2012 Page: 945-954
Author(s): A. Guarini, C. Minoia, M. Giannoccaro, A. Rana, A. Iacobazzi, A. Lapietra, A. Raimondi, N. Silvestris, C. D. Gadaleta, G. Ranieri
Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/ Refractory Diffuse Large B Cell Lymphoma
Journal: Current Stem Cell Research & Therapy
Volume: 12 Issue: 1 Year: 2017 Page: 14-18
Author(s): Zhengrui Xiao, Jianyong Li, Kourong Miao
ICE Regimen for Relapsed/Refractory Bone and Soft Tissue Sarcomas in Children
Journal: Reviews on Recent Clinical Trials
Volume: 13 Issue: 2 Year: 2018 Page: 126-131
Author(s): Burca Aydin,Canan Akyuz,Ali Varan,Bilgehan Yalcin,Nilgun Kurucu,Tezer Kutluk
Sorafenib as a Salvage Therapy in FLT3-ITD Negative Relapse/ Refractory Acute Myeloid Leukemia
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18 Issue: 10 Year: 2018 Page: 1489-1494
Author(s): Nan Yang,Zhenyang Gu,Zhanxiang Liu,Wenrong Huang,Shuhong Wang,Lili Wang,Chunji Gao
Metronomic Therapy for Multi Relapsed/Refractory Lymphoma. A Pilot Study
Journal: Current Angiogenesis (Discontinued)
Volume: 2 Issue: 2 Year: 2013 Page: 119-125
Author(s): Shebli Atrash,Bakhous Aziz,Xenofon Papanikolaou,Abdallah Al-Ola,Muzaffar Jameel,Kumar Surachit,Sarah Waheed,Frits Van Rhee,Saad Z. Usmani,Bart Barlogie
Pirtobrutinib: First Non-covalent Tyrosine Kinase Inhibitor forTreating Relapsed or Refractory Mantle Cell Lymphoma in Adults
Journal: Current Medicinal Chemistry
Volume: 31 Issue: 30 Year: 2024 Page: 4757-4762
Author(s): Surya K. De
Enasidenib: First Mutant IDH2 Inhibitor for the Treatment of Refractory and Relapsed Acute Myeloid Leukemia
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18 Issue: 14 Year: 2018 Page: 1936-1951
Author(s): Raghav Dogra,Rohit Bhatia,Ravi Shankar,Parveen Bansal,Ravindra K. Rawal
Preliminary Experience with Yttrium-90-labelled Rituximab (Chimeric Anti CD-20 Antibody) in Patients with Relapsed and Refractory B Cell Non-Hodgkins Lymphoma
Journal: Current Radiopharmaceuticals
Volume: 9 Issue: 2 Year: 2016 Page: 160-168
Author(s): Parul Thakral,Suhas Singla,Atul Vashist,Madhav P. Yadav,Santosh K. Gupta,Jaya S. Tyagi,Atul Sharma,Chandra S. Bal,Snehlata,Arun Malhotra
CD123: A Novel Biomarker for Diagnosis and Treatment of Leukemia
Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 19 Issue: 3 Year: 2019 Page: 195-204
Author(s): Mingyue Shi,Ruijun J. Su,Kamal-Preet Parmar,Rahman Chaudhry,Kai Sun,Jianyu Rao,Mingyi Chen